A carregar...

Intestinal enteroids/organoids: A novel platform for drug discovery in inflammatory bowel diseases

The introduction of biologics such as anti-tumor necrosis factor (TNF) monoclonal antibodies followed by anti-integrins has dramatically changed the therapeutic paradigm of inflammatory bowel diseases (IBD). Furthermore, a newly developed anti-p40 subunit of interleukin (IL)-12 and IL-23 (ustekinuma...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Gastroenterol
Main Authors: Yoo, Jun-Hwan, Donowitz, Mark
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Inc 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6700704/
https://ncbi.nlm.nih.gov/pubmed/31435168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v25.i30.4125
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!